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ABSTRACT
Background: Treatment for colorectal cancer (CRC) may 
result in physical, social, and psychological needs that affect 
patients’ quality of life post-treatment. A comprehensive 
assessment should be conducted to identify these needs in CRC 
patients post treatment, however, there is a lack of tools and 
processes available in general practice.
Aims: This study aimed to develop a patient-completed 
needs screening tool that identifies potentially unmet physical, 
psychological, and social needs in CRC and facilitates 
consultation with a general practitioner (GP) to address these 
needs.
Methods: The development of the self-assessment tool for 
patients (SATp) included a review of the literature; face and 
content validity with reference to an expert panel; psychometric 
testing including readability, internal consistency, and test–
retest reliability; and usability in clinical practice.
Results: The SATp contains 25 questions. The tool had 
internal consistency (Cronbach’s alpha 0.70–0.97), readability 
(reading ease 82.5%), and test–retest reliability (kappa 0.689–
1.000). A total of 66 patients piloted the SATp. Participants 
were on average 69.2 (SD 9.9) years old and had a median 
follow-up period of 26.7 months. The SATp identified a total 
of 547 needs (median 7 needs/per patient; IQR [3–12.25]). 
Needs were categorised into social (175[32%]), psychological 
(175[32%]), and physical (197[36%]) domains.
Conclusion: SATp is a reliable self-assessment tool useful 
for identifying CRC patient needs. Further testing of this tool 
for validity and usability is underway.
Keywords: colorectal cancer, needs assessment, tool 
development, follow-up care, patient unmet needs
Summary Statement
What do we know?
• Treatment for CRC results in long-term side effects.
• Assessment of CRC-related needs and side effects is important in determining ongoing care for CRC patients.
• Available needs assessment tools are not relevant to specifically capture long-term CRC side effects.
There is no documented CRC needs assessment tool used in general practice for assessing long-term side effects of treatment.
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Background
Treatment for CRC is associated physical, social, and 
psychological side effects that affect patients’ quality of life 
many years after completing treatment. Although acute side 
effects diminish after treatment completion some symptoms 
persist for years including fatigue, sleep difficulty, fear of 
recurrence, anxiety, depression, negative body image, activity 
limitation, sensory neuropathy, gastrointestinal problems, 
urinary complications, and sexual dysfunction.1,2
There is evidence that these symptoms are not always 
identified during a routine doctor–patient consultation. The 
reasons for non-identification include patients’ reluctance to 
initiate a discussion about the needs and health professionals’ 
failure to prompt about these needs during a clinical consultation.3 
Consequently, issues may go unchecked or result in delayed 
diagnosis and/or treatment.
Regular assessment of CRC-related needs and side-effects 
has recently received attention as being important in the ongoing 
management of patients.4 Assessing and attending to needs 
is an important step towards patient-centred care as a failure 
to manage these needs appropriately can lead to poor quality 
of life.5 A standardised screening tool that identifies physical, 
psychological, and social issues could facilitate consultation 
between patients and health professionals to address these needs.6
To date, relatively few needs assessment tools have been 
developed with a focus on long-term side effects. Such tools 
need to be designed for use in a general practice setting where 
most of the oncology patients receive ongoing treatment for 
other chronic illnesses.
Many instruments assessing physical and psychosocial 
side effects of cancer treatment are available, which 
include Supportive Care Needs Survey (SCNS), EORTC 
PR29,Supportive Needs Screening Tool (SNST), and Cancer 
Survivors’ Unmet Needs measure (CaSUN).3,5,7,8 Some items 
measured by these questionnaires are relevant, but others are 
not specific to CRC. Cancer patients’ needs vary depending on 
the type of cancer and the clinical/pathological stage of disease. 
For example, the needs of stage IV cancer patients differ greatly 
from those with stages I–III.2,5 Moreover, these tools have not 
been integrated into primary care practice. 
This article reports the development of patient-administered 
needs assessment instrument to guide CRC patients to identify 
their needs and, where appropriate, consult with their GP.
The specific objectives of the current study were to develop 
a patient-completed needs screening tool that:
1. Screens the unmet needs of CRC patients,
2. Identifies potentially unmet physical, psychological and 
social needs,
3. Is valid and reliable.
Structural framework
The structure of this tool is based on a framework by Pigott 
et al. and Bonevski et al. which suggests a seven criteria should 
be used to determine the effectiveness of needs screening tools 
in cancer follow-up care.3,7
The self-assessment tool for patients (SATp) has several 
properties: (1)contains integrated physical, psychological, 
and social aspects to measure multiple domains of CRC care; 
these domains have also been adopted by Jiwa et al.9  in a needs 
assessment for breast cancer patients; (2) uses a self-reporting 
approach to facilitate direct and comprehensive assessment of 
subjective health needs; (3) measures the needs within a defined 
temporal context—questions relate to needs experienced in the 
previous 4weeks. As advocated by the Pigott et al. study, the 
timeframes used should be useful for clinicians to develop a 
clear understanding of patients’ needs; (4) demonstrates validity 
and reliability through expert review, test–retest and pilot testing 
to provide a sound basis for comparison; (5) embraces a user-
friendly response framework—yes/no responses  to simplify 
the questions for the patient and prompts the clinician to probe 
further; (6) contains only 25 items and is ‘systemfriendly’ by 
minimising patient and staff time to complete and review, 
respectively; and (7) provides an opportunity for the clinician 
to link patients to services—this tool is meant to be a guide 
to consultation, to assist in a thorough exploration of possible 
issues or problems.3
Materials and methods.
The construction of the SATp was based on a review of CRC 
survivorship literature and subjected to a series of validations. 
The items included focused on long-term issues experienced by 
patients offered treatment with curative intent (stages I–III). The 
needs of those with stage IV CRC are entirely different, in most 
cases they are palliative,and thuswere not included.5
Item generation
A systematic search was performed using PubMed/Medline, 
CINHAL, and Cochrane Online Library (reviews and trials) 
databases from 1980 to 2014. Search terms were used either 
singularly or in combination in the index lists of the relevant 
databases. The search terms used were ‘lower bowel cancer ’, 
‘rectal cancer’, ‘colon cancer’, ‘effects of treatment’, ‘effects 
of adjuvant therapy’, ‘effects of surgery’, ‘follow-up care’, 
‘survivorship care’, ‘quality of life’, and ‘patient unmet needs’. 
Free text words were used to supplement the medical subject 
heading (MeSH) search terms in the case of Medline.
The reviews focused on long-term effects of CRC treatment 
and their prevalence. Titles and abstracts of 650 references were 
reviewed and 69 studies satisfied the following inclusion criteria 
Figure 1
(1) Published in English 
(2) Reported empirical research 
What does this paper add?
• This paper reports the development of a reliable and valid needs assessment tool that is specific for CRC and long-term 
side effects of its treatment.
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(3) Reported on epidemiology of CRC
(4) Focused on developing a symptoms/needs assessment 
questionnaire for patients post cancer treatment, in 
particular, CRC
(5) Reported side effects of CRC treatment
(6) Focused on patients’ quality of life after CRC treatment
From the 69 reviewed papers, 340 needs were extracted. 
Duplicates were removed yielding 100 items. These items were 
then assessed for face validity by a team of three clinicians 
(medical doctor, public health specialist, and nurse). Unclear 
items and those with similar meanings were identified and 
removed leaving problems/issues considered common one 
year or more after treatment completion. Thirty-two problems 
were grouped into three domains: psychological (n=6), physical 
(n=20), and social (n=6) Figure 2 as advocated by Pigott et al. 
and Jiwa et al.3, 9
Item reduction
The 32 identified items were further reduced through 
modelling for frequencies based on published prevalence of 
the side effects. Any items that had a frequency of ≤5 were 
removed as this was deemed as uncommon by the expert panel. 
The modelling was based on a typical cohort of 100 patients 
with CRC.
From the reviewed articles, the epidemiology of CRC 
suggests that approximately 70% of cases are located in the 
colon and 30% in the rectum.10 As shown in Figure 3, 50% of 
patients with colon cancer are likely to be in stage II or III at 
diagnosisbut rectal cancer cases are evenly spread across all 
stages.20,21
For stages I–III CRC, nearly all patients(98%) undergo 
surgery,but treatment with chemotherapy and radiotherapy 
depends on the location (colon or rectum) and the stage. For 
colon cancer, the majority (75.5%) of stage III patients get 
chemotherapy, while for stages I and II percentages are lower 
as there is no general agreement on its use in these patients. 22- 24 
Approximately 19.6% of patients are offered chemotherapy in 
stage Iand 20–24% in stage II.25,26 Radiotherapy has a limited 
role in the treatment of colon cancer, but for rectal cancer 
patients it may be offered at all stages:stage I, 19.6%;stage II, 
36%; and stage III, 57%.22,25,26
Furthermore, literature suggests that patients may have 
treatment side effects in the physical, psychological, and social 
domains.1,27,28 The prevalence of the published side effects under 
these domains have been summarised in Figure 3. Most side 
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a Sexual dysfunction was identified as both a physical and psychological problem


































Excluded (22.5% Stage IV and 3–5% un-staged)
Physical
Weight loss n = 1–6 (5–55%[1])
Peripheral-neuropathy: n = 4 (12%[10])
Nausea/vomiting: n = 1–6 (5–55%[1])
Fatigue: n = 17 (23%[1])
Pain and cramping: n = 5 (7%[1])
Psychological
*Negative body image: n = 6 (25%)
*Sexual dysfunction: n = 6 (26%[1, 5, 6])
Depression: n = 19 (25%[7])
Fear of recurrence: n = 50 (67–68%[6-8])
Anxiety: n = 5 (7%[7])
Poor sleep pattern: n = 36 (48%[9])
Physical
Diarrhoea: n = 10 (13–14%[1-4])
Constipation: n = 5 (7%[1])
BO urgency: n = 15 (20–22%[2, 3])
Faecal incontinence: n = 10 (14–16%[2, 3])
Urine incontinence: n = 9 (38%[1])
Urine retention: n = 7 (31%[1])
Social
Activity limitation: n = 11 (15%[3])
Financial difficulties: n = 35 (48.8%[11])
Figure 3: Distribution of side-effects based on a cohort of 100 people with CRC.
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effects in the physical domain include bowel (7–20%),urinary 
(31–38%), and sexual dysfunction(26%).1,2,11,12,15,17 Long-term 
psychological issues commonly reported are fear of recurrence 
(67–68%) followed by depression (25%).1,15-17 For social prob-
lems, the greatest burden is financial difficulties (~50%)fol-
lowed by activity limitation (15%).9,21
Based on these statistics, it is anticipated that in a sample 
of 100 stage I–III CRC patients (excluding 22.5% stage IV and 
3–5% unstaged CRC)with typical epidemiology as above, 53 
will have colon cancer and 22 will have rectal cancer. Of these, 
75 patients will receive surgery, 36 will be offered chemotherapy, 
and 11 will be offered radiotherapy Figure 3. 
Further modelling of this group to illustrate the frequency 
of treatment effects in the cohort, shows that five to ten patients 
will have some form of bowel dysfunction. It is anticipated 
that about seven to nine patients with rectal cancer (a cohort 
of 23 patients) who have had surgery and radiotherapy will 
report urological dysfunction. From this cohort, four patients 
offered chemotherapy will experience some form of peripheral 
neuropathy and at least one to six patients will experience 
nausea, vomiting, and weight loss related to chronic radiation 
enteritis.1Six rectal cancer patients will experience some form 
of sexual dysfunction.
The extent of psychological and social factors experienced 
by the whole cohort (colon and rectal) will be high. Nearly 50 
patients will suffer some form of psychosocial problem. For 
example, about 50 patients will have fear of recurrence Figure 3. 
Based on the modelling, items with fewer than five patients 
in the cohort were removed from the list. Two items (fractures 
and dysuria) were excluded. The results of cohort modelling 
identified 26 items. These items were used to formulate initial 
SATp questions, which were further subjected to a series of 
validation and testing. 
Content validity
Content was tested through a Delphi technique (‘a method 
for the systematic solicitation and collation of judgements on a 
particular topic through a set of carefully designed questionnaires 
interspersed with summarised information and feedback of 
opinions derived from earlier responses'  - pg. 606).29
Seven health professionals—surgeon, radiation oncologist, 
medical oncologist, clinical nurse specialist, psychologist, 
occupational therapist, and dietician—were invited to join a 
Delphi panel. They were asked to rate the level of importance 
of each question based on evidence and list other questions they 
considered important in detecting ongoing or new problems in 
CRC patients during follow-up period. 
Average scores for these items were calculated and sent 
back to the panellists to rate their level of agreement with 
these counts. Coordination of the expert suggestions (each 
Delphi) was performed by the researcher until a consensus on 
the questions was reached. This list of items was also sent to a 
group of six patients who had completed CRC treatment to rate 
the importance of raising these issues with their doctor. Average 
scores were generated and returned to the patients to rate their 
level of agreement with the count.
The 26 questions were rated on a Likert scale by a panel of 
health professionals and patients and 90% had total scores >3 out 
of a maximum score of 5.Scores ≥3 were regarded by the panel 
as indicating high relevance. One physical item (constipation) 
and one social need (information need) having a score of 2 were 
removed from the list. Four other questions were combined 
into two as they tested the same issue (sexual dysfunction for 
males and females, and frequent bowel movements during night 
and day) (Figure 2).An additional two items suggested by the 
panel (dietary advice and troublesome flatulence) were added 
to the list. In total, 25 questions were included in the SATp 
questionnaire Figure 2.
Readability
This list of questions was subjected to Flesch–Kincaid 
readability test for functions of the number of characters, 
syllables, words, or sentences in a text sample (this test has 
been used extensively to measure the readability of health 
information).30 This ensured that the tool could easily be 
understood by high school graduates—the minimum level of 
compulsory school education in Australia.
A grade of 4.4 reading level was attained (acceptable range, 
grades4–6) and reading ease was 82.5% (maximum reading ease 
is 100%; the higher the number, the easier it is for participants 
to read). On average, SATp takes approximately 5 minutes to 
be completed.
Data analysis
Statistical analysis of SATp was conducted using SPSS 
version 19.31 The kappa coefficient was used to examine test–
retest reliability at the item level and Cronbach’s alpha was 
computed to assess internal consistency. Delphi results of the 
panellist score were computed and average scores calculated. 
Items with an average score of <3 out of 5 for healthcare 
workers and patients were excluded from the list. Descriptive 
statistics were used to summarise patients’ demographics, 
clinical characteristics, and needs identified by SATp.
Sample and study setting 
Participants aged ≥ 18 years, who had been offered treatment 
with curative intent (stages I–III), had completed CRC treatment, 
and had been followed up for at least one year in the outpatient 
cancer clinic were eligible for inclusion in this study.
Eligible participants were asked to sign the consent form 
and nominate their GP. Once the completed consent form was 
received, they were sent a copy of the SATp, which they were 
expected to complete. 
A protocol of reminder telephone calls and letters was 
followed to enhance study compliance. The study was approved 
by the relevant human research ethics committees from the 
participating hospital and university (QI3041 and HR 42/2012, 
respectively). 
Pre-test
Test–retest reliability was assessed by administering 
the tool to a subset of participants who agreed to fill out the 
questionnaire on two occasions, approximately 2 weeks apart. 
The questionnaire was sent to 30 participants and then re-sent 
14 days later. 
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The kappa statistic (κ) was calculated to assess the test–re-
test reliability of the instrument. Kappa can range between 1 
(perfect agreement) and a little less than 0 (no agreement); A κ 
value of >0.80 is considered to reflect almost perfect agreement, 
0.61–0.80 substantial agreement, 0.41–0.60 moderate agree-
ment, and 0.21–0.40 fair agreement.32 The question by question 
comparison showed substantial agreement with kappa in the 
range of 0.689 –1.000 for all questions.
The 25-item SATp achieved moderate to high internal 
consistency as demonstrated by Cronbach’s alpha coefficients 
for the three domains (psychological, social, and physical) 
ranging from 0.706 to 0.903. Item-to-total score correlation 
coefficients for all items exceeded 0.595. This showed that 
questions within each of the three domains were assessing 
different aspects of the same construct.
Needs identified
Of the 250 CRC patients attending the target outpatient 
services, 88 were eligible. Patients with stage IV cancer (n=39), 
non-English speaking (n=2), were living in aged care facilities 
(n=6), and had completed treatment less than 12months ago 
(n=107) were not included. Of the 88 eligible participants, 
66 consented and returned the completed questionnaires. 
Participants were on average 69.2 (SD 9.9) years old and had 
been diagnosed with cancer 26.7 months earlier (range 6–92, 
median 28). As shown in Table 1, 65.2% had colon cancer, 
34.8% had rectal cancer, and 81.8% had one or more coexisting 
chronic illness.
For the 66 participants, a total of 547needs were identified 
by SATp, with an average of 8.1 needs per patient (median 
7; IQR [3-12.25]). Identified needs were in the physical 
(175[32%]), psychological (175[36%]), and social (197[32%]) 
domains. The most commonly reported physical needs were 
troublesome flatulence (79%) and fatigue (41%).Psychological 
needs included fear of recurrence (53%), insomnia (53%), 
sexual dysfunction (36%), anxiety (36%), and negative body 
image (23%). Social needs included dietary advice (41%) and 
housework difficulties (45%) Figure 4.
Participant characteristics (n=66) Number of participants (%)
Gender Male 26 (39.1)
Female 40 (60.9)
Age Mean (SD) 69.2 (9.9)








De-facto partner 1 (1.6)
Education level Completed primary school 7 (10.9)
Year 10 or equivalent 29 (43.8)
Year 12 or equivalent 4 (6.1)
Trade certificate/TAFE 12 (18.2)
University/CAE (College of Advanced Education) 14 (21.2)
Employment Self-employed 4 (6.3)
Employed for wages, salary, or payment in kind 10 (10.6)
Engaged in home duties 1 (1.5)
Unable to work 2 (3.0)
Unemployed 1 (1.5)
Retired 47 (71.2)
Other reasons 4 (6.1)
Cancer location Colon 43 (65.2)
Rectum 23 (34.8)
Cancer stage Stage I 17 (25.8)
Stage II 30 (45.5)
Stage III 19 (28.8)
Comorbidity Yes 54 (81.8)
No 12 (18.2)
* Clinical characteristics were formulated based on patient-assessment questions identified in the Australian guidelines for cancer follow-up (Cancer Council Australia 2004).
Table 1: Participant demographic and clinical characteristics*.
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Discussion
This study reports the development of a reliable and 
valid instrument to assist doctors and patients in identifying 
symptoms/problems that may stem from CRC treatment. SATp 
satisfies the prerequisites for assessing the long-term needs of 
CRC survivors as it measures multiple dimensions of CRC-
related needs. 
The items included in SATp have been developed through 
a rigorous literature review and by modelling the items into a 
simulated cohort of CRC patients to derive the most common 
symptoms experienced by this group. Furthermore, the 
instrument has integrated the experience of patients in follow-
up care and expert input from health professionals involved in 
the care of CRC patients. 
Preliminary results indicate that SATp fulfils the current 
methodological standards for acceptability, internal consistency, 
validity, and usability. Through an internal consistency process, 
it was possible to demonstrate evidence for a strong, structurally 
reliable SATp with Cronbach’s alpha coefficients exceeding 0.7 
in all three domains. The test–retest reliability also showed a 
level of agreement that was not due to chance, as was evidenced 
by a kappa of 0.689–1.000. 
Despite being at 1yearpost-treatment, each patient was 
experiencing a median of 7 unmet needs, all in the three domains 
(physical, psychological, and social). These domains have been 
reported with past research suggesting that these issues are 
important aspects for long-term survivors of CRC.1
The initial results confirm that the tool can be self-
administered. By examining the needs rated as ‘yes’, the survey 
could potentially be used to alert practitioners to refer these 
patients to secondary care or other appropriate allied health 
support services. For this instrument to be useful, regular usein 
general practice is required. Also, it is yet to be shown whether 
SATp facilitates proactive management of related problems in 
general practice and how GPs might address some problems 
identified such as fear of recurrence. This evidence will be 
outlined in the second part of this study. The research team 
is currently in the process of trailing SATp longitudinally to 
further test its value for regular use in a general practice setting. 
Despite these limitations, the research outlines some of the 
practical and operational benefits of a specific instrument for CRC 
patients attending general practice. Furthermore, the practicality 
of self-administration of this measure obviates the need for 
follow-up phone interviews from health professionals. Thus, this 
instrument increases the practical feasibility and acceptability of 
assessing patient needs on an ongoing basis as a routine part of 
care. The application of the instrument in general practice may 
potentially yield a valuable pool of data on patient needs.
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